Regulatory report: Lithuania, August 2020

Lithuania distinguishes cannabis and industrial hemp by the THC concentration of 0.2%. CBD extracts, full spectrum and finished products are not allowed on the market, but bill XIIIP-3195 (2) could legalise these products. This report offers a detailed analysis of the current regulatory framework in Lithuania and also discusses possible future regulation and how it might affect the current regime. The report covers all aspects of law including extracts, finished products, import and export rules, and medical and recreational cannabis.

Free Sample
I'm already a subscriber
Author default picture

CannIntelligence

This article was written by one of CannIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual cannabis and cannabinoid markets. For a full list, please see our Who We Are page.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization